Niche anchorage and signaling through membrane‐bound Kit‐ligand/c‐kit receptor are kinase independent and imatinib insensitive

S Tabone‐Eglinger, Z Calderin‐Sollet… - The FASEB …, 2014 - Wiley Online Library
Kit ligand (KitL) and its tyrosine kinase receptor c‐kit are critical for germ cells, melanocytes,
mastocytes, and hematopoietic stem cells. Alternative splicing of KitL generates membrane …

Phosphatidylinositol 3′-kinase is required for growth of mast cells expressing the kit catalytic domain mutant

R Shivakrupa, A Bernstein, N Watring, D Linnekin - Cancer research, 2003 - AACR
The Kit receptor tyrosine kinase is critical for the growth and development of hematopoietic
cells, germ cells, and the interstitial cells of Cajal. Gain-of-function mutations in codon 816 of …

Mechanism of activation of human c-KIT kinase by internal tandem duplications of the juxtamembrane domain and point mutations at aspartic acid 816

SY Kim, JJ Kang, HH Lee, JJ Kang, BK Kim… - Biochemical and …, 2011 - Elsevier
The proto-oncogene c-KIT receptor has been implicated as an essential component in the
activation of leukemic cells. The internal tandem duplication (ITD) of c-KIT has also been …

KIT as a therapeutic target for non-oncological diseases

A Martinez-Anton, D Gras, A Bourdin, P Dubreuil… - Pharmacology & …, 2019 - Elsevier
KIT is a receptor tyrosine kinase that after binding to its ligand stem cell factor activates
signaling cascades linked to biological processes such as proliferation, differentiation …

[PDF][PDF] Amplification of a novel c-Kit activating mutation Asn^ 8^ 2^ 2-Lys in the Kasumi-1 cell line: at (8; 21)-Kit mutant model for acute myeloid leukemia

A Beghini, I Magnani, CB Ripamonti… - The Hematology …, 2002 - researchgate.net
Results: We identified in the Kasumi-1 cell line a novel Asn822Lys ligand-independent c-kit
activating mutation and demonstrated by semiquantitative PCR that the mutated allele is …

C-KIT signaling in cancer treatment

K Stankov, S Popovic, M Mikov - Current pharmaceutical …, 2014 - ingentaconnect.com
Tumor progression is strongly associated with the activity of receptor tyrosine kinases
(RTKs) and their intracellular signal transduction pathways, which regulate several cell …

Inhibitors to overcome secondary mutations in the stem cell factor receptor KIT

H Kaitsiotou, M Keul, J Hardick… - Journal of medicinal …, 2017 - ACS Publications
In modern cancer therapy, the use of small organic molecules against receptor tyrosine
kinases (RTKs) has been shown to be a valuable strategy. The association of cancer cells …

c-Kit—a hematopoietic cell essential receptor tyrosine kinase

CE Edling, B Hallberg - The international journal of biochemistry & cell …, 2007 - Elsevier
The receptor tyrosine kinase c-Kit is expressed in hematopoietic stem and progenitor cells
and in several non-hematopoietic tissues. In the hematopoietic system, c-Kit is critical for …

Necessity of tyrosine 719 and phosphatidylinositol 3′-kinase–mediated signal pathway in constitutive activation and oncogenic potential of c-kit receptor tyrosine …

K Hashimoto, I Matsumura, T Tsujimura… - Blood, The Journal …, 2003 - ashpublications.org
Substitution of valine (Val) for aspartic acid (Asp) at codon 814 constitutively activates
murine c-kit receptor tyrosine kinase (KIT), and Asp816Val mutation, corresponding to …

KITD816V Induces SRC-Mediated Tyrosine Phosphorylation of MITF and Altered Transcription Program in Melanoma

B Phung, JU Kazi, A Lundby, K Bergsteinsdottir… - Molecular Cancer …, 2017 - AACR
The oncogenic D816V mutation of the KIT receptor is well characterized in systemic
mastocytosis and acute myeloid leukemia. Although KITD816V has been found in …